VCX: A Potential Drug Target and Biomarker (G26609)

Target Name: VCX

NCBI ID: G26609

Content of Review Report on VCX Target / Biomarker

VCX

VCX: A Potential Drug Target and Biomarker

VCX (Variable charge X-linked) is a protein that is expressed in various tissues of the human body, including the brain, heart, and skeletal muscles. It is a unique protein that has been identified as a potential drug target and biomarker. In In this article, we will explore the biology of VCX, its potential as a drug target, and its potential as a biomarker for various diseases.

Biochemistry and Structure

VCX is a member of the X-linked transmembrane protein family, which includes several other proteins, including the neurotransmitter receptor subfamily 2 (尾2) receptor. These proteins are characterized by the presence of a variable charge on their transmembrane region, which is influenced by the presence of intracellular electrolytes.

VCX has a molecular weight of approximately 41 kDa and a pre-polarization charge of +650 mV. It has a single transmembrane domain and a N-terminus that is involved in protein-protein interactions. The C-terminus of VCX contains a unique farnesylated cysteine 鈥嬧?媟esidue, which is important for its stability and localization to the endoplasmic reticulum (ER).

Function

VCX is involved in several physiological processes in the body, including muscle contractions, blood pressure, and cell signaling. It is a key regulator of muscle contractions and has been shown to play a role in the regulation of myopathic diseases, such as dystrophied muscles and myopathic fibromyalgia.

VCX is also involved in the regulation of blood pressure and has been shown to play a role in the pathophysiology of hypertension. It has been shown to increase blood pressure in response to increased intracellular pressure and to decrease blood pressure in response to decreased intracellular pressure.

VCX is involved in several signaling pathways, including the TGF-β pathway and the Wnt pathway. It has been shown to play a role in the regulation of cell proliferation, differentiation, and survival.

Drug Target Potential

VCX is a potential drug target due to its unique structure and its involvement in several physiological processes. One of the main reasons for its potential as a drug target is its high surface area, which allows for the production of small, potent drugs that can interact with a wide range of mechanisms.

VCX has been shown to play a role in the regulation of myopathic diseases, such as dystrophied muscles and myopathic fibromyalgia. It has been shown to regulate muscle contractions and to play a role in the regulation of myopathic diseases.

VCX has also been shown to be involved in the regulation of blood pressure and has been shown to play a role in the pathophysiology of hypertension. It has been shown to increase blood pressure in response to increase intracellular pressure and to decrease blood pressure in response to decreased intracellular pressure.

VCX is also involved in several signaling pathways, including the TGF-β pathway and the Wnt pathway. It has been shown to play a role in the regulation of cell proliferation, differentiation, and survival.

Biomarker Potential

VCX has the potential to serve as a biomarker for several diseases, including myopathic diseases, hypertension, and cancer. Its unique structure and its involvement in several physiological processes make it an attractive candidate for use as a biomarker.

VCX has been shown to play a role in the regulation of myopathic diseases, such as dystrophied muscles and myopathic fibromyalgia. It has been shown to regulate muscle contractions and to play a role in the regulation

Protein Name: Variable Charge X-linked

Functions: May mediate a process in spermatogenesis or may play a role in sex ratio distortion

The "VCX Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about VCX comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets